512 related articles for article (PubMed ID: 26384169)
1. Activity of andrographolide against chikungunya virus infection.
Wintachai P; Kaur P; Lee RC; Ramphan S; Kuadkitkan A; Wikan N; Ubol S; Roytrakul S; Chu JJ; Smith DR
Sci Rep; 2015 Sep; 5():14179. PubMed ID: 26384169
[TBL] [Abstract][Full Text] [Related]
2. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses.
Varghese FS; Kaukinen P; Gläsker S; Bespalov M; Hanski L; Wennerberg K; Kümmerer BM; Ahola T
Antiviral Res; 2016 Feb; 126():117-24. PubMed ID: 26752081
[TBL] [Abstract][Full Text] [Related]
3. Andrographolide Mitigates Unfolded Protein Response Pathway and Apoptosis Involved in Chikungunya Virus Infection.
Gupta S; Mishra KP; Kumar B; Singh SB; Ganju L
Comb Chem High Throughput Screen; 2021; 24(6):849-859. PubMed ID: 32819227
[TBL] [Abstract][Full Text] [Related]
4. Andrographolide - A prospective remedy for chikungunya fever and viral arthritis.
Gupta S; Mishra KP; Gupta R; Singh SB
Int Immunopharmacol; 2021 Oct; 99():108045. PubMed ID: 34435582
[TBL] [Abstract][Full Text] [Related]
5. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.
Rothan HA; Bahrani H; Abdulrahman AY; Mohamed Z; Teoh TC; Othman S; Rashid NN; Rahman NA; Yusof R
Antiviral Res; 2016 Mar; 127():50-6. PubMed ID: 26794398
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection.
Oo A; Rausalu K; Merits A; Higgs S; Vanlandingham D; Bakar SA; Zandi K
Antiviral Res; 2018 Feb; 150():101-111. PubMed ID: 29269135
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
mBio; 2016 May; 7(3):. PubMed ID: 27222471
[TBL] [Abstract][Full Text] [Related]
8. Suramin inhibits chikungunya virus replication through multiple mechanisms.
Albulescu IC; van Hoolwerff M; Wolters LA; Bottaro E; Nastruzzi C; Yang SC; Tsay SC; Hwu JR; Snijder EJ; van Hemert MJ
Antiviral Res; 2015 Sep; 121():39-46. PubMed ID: 26112648
[TBL] [Abstract][Full Text] [Related]
9. Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry.
Henß L; Beck S; Weidner T; Biedenkopf N; Sliva K; Weber C; Becker S; Schnierle BS
Virol J; 2016 Aug; 13(1):149. PubMed ID: 27581733
[TBL] [Abstract][Full Text] [Related]
10. Activity of andrographolide against dengue virus.
Panraksa P; Ramphan S; Khongwichit S; Smith DR
Antiviral Res; 2017 Mar; 139():69-78. PubMed ID: 28034742
[TBL] [Abstract][Full Text] [Related]
11. Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.
Bouma EM; van de Pol DPI; Sanders ID; Rodenhuis-Zybert IA; Smit JM
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321803
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of new potent inhibitors of dengue virus NS5 proteinase from Andrographis paniculata supercritical extracts on in animal cell culture and in silico approaches.
Kaushik S; Dar L; Kaushik S; Yadav JP
J Ethnopharmacol; 2021 Mar; 267():113541. PubMed ID: 33152438
[TBL] [Abstract][Full Text] [Related]
13. Micafungin is a novel anti-viral agent of chikungunya virus through multiple mechanisms.
Ho YJ; Liu FC; Yeh CT; Yang CM; Lin CC; Lin TY; Hsieh PS; Hu MK; Gong Z; Lu JW
Antiviral Res; 2018 Nov; 159():134-142. PubMed ID: 30300716
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of nobiletin against chikungunya virus in vitro.
Lin SC; Chen MC; Li S; Lin CC; Wang TT
Antivir Ther; 2017; 22(8):689-697. PubMed ID: 28406093
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of a peptide-fusion protein (Latarcin-PAP1-Thanatin) against chikungunya virus.
Rothan HA; Bahrani H; Shankar EM; Rahman NA; Yusof R
Antiviral Res; 2014 Aug; 108():173-80. PubMed ID: 24929084
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of transient receptor potential vanilloid 1 (TRPV1) channel regulates chikungunya virus infection in macrophages.
Sanjai Kumar P; Nayak TK; Mahish C; Sahoo SS; Radhakrishnan A; De S; Datey A; Sahu RP; Goswami C; Chattopadhyay S; Chattopadhyay S
Arch Virol; 2021 Jan; 166(1):139-155. PubMed ID: 33125586
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of medicinal herbs for Anti-CHIKV activity.
Raghavendhar S; Tripati PK; Ray P; Patel AK
Virology; 2019 Jul; 533():45-49. PubMed ID: 31082733
[TBL] [Abstract][Full Text] [Related]
18. Suramin Inhibits Chikungunya Virus Entry and Transmission.
Ho YJ; Wang YM; Lu JW; Wu TY; Lin LI; Kuo SC; Lin CC
PLoS One; 2015; 10(7):e0133511. PubMed ID: 26208101
[TBL] [Abstract][Full Text] [Related]
19. The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling.
Varghese FS; Thaa B; Amrun SN; Simarmata D; Rausalu K; Nyman TA; Merits A; McInerney GM; Ng LFP; Ahola T
J Virol; 2016 Nov; 90(21):9743-9757. PubMed ID: 27535052
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression.
Kaur P; Thiruchelvan M; Lee RC; Chen H; Chen KC; Ng ML; Chu JJ
Antimicrob Agents Chemother; 2013 Jan; 57(1):155-67. PubMed ID: 23275491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
